Skip to main content

Table 3 Patient-Reported Outcomes Related to Distress

From: Patient-reported outcomes associated with cancer screening: a systematic review

 

Study Design

Screening

Measure†

Result

Screening

2 mo

3 mo

4 mo

5 mo

6 mo

7 mo–11 mo

12 mo

Baseline

Within 1 mo

Mean (SD)

Mean (SD)

Mean (SD)

Ruberg et al 2016 [47]

N = 180 (Total)

N = 16 (Abnormal)

• Age: 30–60 years

• Women living in Netherlands

Prospective longitudinal

TVS/CA125

IES-intrusive

Total (Abnormal, Normal)

3.5 (5.6)

3.1 (5.0)

2.4 (4.8)

      

Abnormal

2.9 (4.4)

3.7 (4.7)

6.3 (6.4)

      

Normal

3.6 (5.7)

3.0 (5.1)

2.1 (4.4)*,a

      

van den Bergh et al 2011 [48]

N = 600–658

• Age: 50–75 years

• NELSON study participants

RCT

LDCT

IES (total)

Indeterminate

4.0 (2.8–5.3)

 

7.8 (6.5–9.0)*b

      

(−)

4.1 (3.4–4.8)

 

2.6 (2.0–3.3)

      

IES-intrusive

Indeterminate

1.9 (1.3–2.4)

 

3.4 (2.8–3.9)

      

(−)

1.7 (1.4–2.0)

 

1.0 (0.7–1.3)

      

IES-avoidance

Indeterminate

2.2 (1.4–3.0)

 

4.4 (3.6–5.2)

      

(−)

2.3 (1.9–2.8)

 

1.7 (1.2–2.1)

      

van den Bergh et al 2010 [41]

N = 600–641

• Age: 50–75 years

• NELSON study participants

RCT

LDCT

IES (total)

Indeterminate

4.5 (6.5)

4.9 (8.4)

8.3 (11.3)*,c

      

(−)

4.1 (7.4)

4.5 (7.7)

2.4 (5.5)*d

      

IES-intrusive

Indeterminate

2.0 (3.0)

2.0 (3.8)

3.5 (5.2)

      

(−)

1.7 (3.5)

1.8 (3.5)

0.8 (2.4)

      

IES-avoidance

Indeterminate

2.5 (4.1)

2.9 (4.9)

4.8 (6.9)*c

      

(−)

2.4 (3.7)

2.7 (4.7)

1.5 (3.7)

      

van den Bergh et al 2008 [43]

N = 288–324

• Age: 50–75 years

• NELSON study participants

RCT

LDCT

IES (total)

Total (−/Incidental)

3.0e

1.0e

      

2.0e

IES-intrusive

1.0e

0.0e

      

0.0e

IES-avoidance

1.0e

0.0e

      

1.0e

Bunge et al 2008 [49]

N = 40–47 (High AR)

N = 236–247 (Low AR)

• Age: 50–75 years

• NELSON study participants

RCT

LDCT

IES (total)

High AR

11.5e

     

6.5e,f,*

  

Low AR

2.0e

     

1.0e,*

  

IES-intrusive

High AR

5.0e

     

3.5e,*

  

Low AR

1.0e

     

0.0e,*

  

IES-avoidance

High AR

5.0e

     

3.0e,*

  

Low AR

1.0e

     

0.5e,*

  
  1. *Indicating statistical significance, p < 0.05
  2. †IES, IIRS: higher scores indicate more distress
  3. aLevels of distress decreased upon receipt of normal scan results (p = 0.007), when compared to after screening
  4. bClinically relevant (MID = half an SD) and significantly higher levels of distress from baseline to 2 months in indeterminate group, compared to the (−) group
  5. cClinically relevant (MID = half an SD) and significantly higher levels of distress (MID = half an SD) from baseline to 2 months in indeterminate group, compared to 1 day after screening and before baseline
  6. dClinically relevant (MID = half an SD) and significantly lower levels of distress (MID = half an SD) from baseline to 2 months in (−) group, compared to 1 day after screening and before baseline
  7. eMedian values
  8. fp < 0.01 versus low AR
  9. Abbreviations: AR affective risk, CA-125 ovarian tumor marker, IES impact of event scale, LDCT low-dose computed tomography, NELSON The Dutch-Belgian Randomized Lung Cancer Screening Trial, RCT randomized controlled trial, SD standard deviation, TVS transvaginal ultrasound scan